CoChat

Genetic Modifiers of Fetal Haemoglobin in Sickle Cell Disease

Menzel, Stephan, Thein, Swee Lay · 2019 · Molecular Diagnosis & Therapy

The DOI matches its Crossref record; 59 of the 60 references it cites were found in a registry or an index.

Abstract

Fetal haemoglobin (HbF) levels have a clinically beneficial effect on sickle cell disease (SCD). Patients with SCD demonstrate extreme variability in HbF levels (1-30%), a large part of which is likely genetically determined. The main genetic modifier loci for HbF persistence, HBS1L-MYB, BCL11A and the β-globin gene cluster in adults also act in SCD patients. Their effects are, however, modified significantly by a disease pathology that includes a drastically shortened erythrocyte lifespan with an enhanced survival of those red blood cells that carry HbF (F cells). We propose a model of how HbF modifier genes and disease pathology interact to shape HbF levels measured in patients. We review current knowledge on the action of these loci in SCD, their genetic architecture, and their putative functional components. At each locus, one strong candidate for a causative, functional DNA change has been proposed: Xmn1-HBG2 at the β-globin cluster, rs1427407 at BCL11A and the 3 bp deletion rs66650371 at HBS1L-MYB. These, however, explain only part of the impact of these loci and additional variants are yet to be identified. Further progress in understanding the genetic control of HbF levels requires that confounding factors inherent in SCD, such as ethnic complexity, the role of F cells and the influence of drugs, are suitably addressed. This will depend on international collaboration and on large, well-characterised patient cohorts with genome-wide single-nucleotide polymorphism or se…

Overview

Integrity signals

Registry

Crossref · 10.1007/s40291-018-0370-8

Cites

59 of 59 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Citations

Cites

Show all 59 references

Cited by

See all 60

Metadata

Authors
Menzel, S., & Thein, S. L.
Affiliations
  • King's College London (GB)
  • National Institutes of Health (US)
Corresponding author
  • Menzel, Stephan
  • Thein, Swee Lay
Venue
Molecular Diagnosis & Therapy
Published
2018-11-26
Volume
23
Issue
2
Pages
235-244
ISSN
  • 1177-1062 (ISSN-L)
  • 1179-2000
OpenAlex
W2903560368
Cited by
50
References
60
Citations by year
2026: 2 · 2025: 7 · 2024: 7 · 2023: 6 · 2022: 5 · 2021: 9 · 2020: 11 · 2019: 3
FWCI
0.83
Type
journal article
Language
en
Open access
closed
Licence
www.springer.com/tdm (tdm)
Locations
  • Molecular Diagnosis & Therapy (publishedVersion)
  • PubMed (publishedVersion)
  • Research Portal (King's College London) (submittedVersion)
Topics
  • Health Sciences › Medicine › Genetics (clinical) › Hemoglobinopathies and Related Disorders
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Hemoglobin structure and function
  • Health Sciences › Medicine › Hematology › Blood groups and transfusion
Keywords
sickle cell disease, fetal hemoglobin, genetic modifiers, HBS1L-MYB, BCL11A, beta-globin gene cluster, erythrocyte lifespan, F cells, single nucleotide polymorphisms, genetic architecture
MeSH terms
Gene Editing, Anemia, Sickle Cell, Fetal Hemoglobin, Multigene Family, Humans, beta-Globins, Genes, Modifier

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Genetic Modifiers of Fetal Haemoglobin in Sickle Cell Disease. https://app.cochat.ai/papers/10.1007/s40291-018-0370-8
The paper
Menzel, S., & Thein, S. L. (2019). Genetic Modifiers of Fetal Haemoglobin in Sickle Cell Disease. Molecular Diagnosis & Therapy. https://doi.org/10.1007/s40291-018-0370-8

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.